Advances in the drug management of basal cell carcinoma.

Ramelyte, Egle; Restivo, Gaetana; Mannino, Maria; Levesque, Mitchell P; Dummer, Reinhard

Ramelyte, Egle; Restivo, Gaetana; Mannino, Maria; Levesque, Mitchell P; Dummer, Reinhard.

Afiliação

Ramelyte E; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Restivo G; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Mannino M; Department of Dermatology, Catholic University of the Sacred Heart, Rome, Italy.
Levesque MP; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Dummer R; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Expert Opin Pharmacother ; 23(5): 573-582, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35081851

Assuntos

Antineoplásicos; Carcinoma Basocelular; Neoplasias Cutâneas; Antineoplásicos/farmacologia; Antineoplásicos/uso terapêutico; Carcinoma Basocelular/tratamento farmacológico; Carcinoma Basocelular/patologia; Humanos; Neoplasias Cutâneas/tratamento farmacológico; Neoplasias Cutâneas/patologia; Microambiente Tumoral

Palavras-chave

Basal cell carcinoma; NMSC; hedgehog pathway inhibitors; skin cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma Basocelular / Antineoplásicos Limite: Humans Idioma: En Revista: Expert Opin Pharmacother Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google